| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3982817 | Clinical Radiology | 2011 | 11 Pages |
Abstract
Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
K. Kitajima, K. Murakami, Y. Kaji, S. Sakamoto, K. Sugimura,